The estimated Net Worth of Steven H Collis is at least 107 百万$ dollars as of 8 August 2023. Mr. Collis owns over 10,499 units of Amerisource Bergen stock worth over 48,318,511$ and over the last 21 years he sold ABC stock worth over 47,231,640$. In addition, he makes 11,309,900$ as Chairman of the Board、 President、 Chief Executive Officer at Amerisource Bergen.
Steven has made over 124 trades of the Amerisource Bergen stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 10,499 units of ABC stock worth 813,987$ on 8 August 2023.
The largest trade he's ever made was exercising 245,258 units of Amerisource Bergen stock on 1 May 2013 worth over 3,727,922$. On average, Steven trades about 21,443 units every 40 days since 2003. As of 8 August 2023 he still owns at least 268,466 units of Amerisource Bergen stock.
You can see the complete history of Mr. Collis stock trades at the bottom of the page.
Steven (Steve) H. Collis serves as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Collis is the President and Chief Executive Officer of AmerisourceBergen Corporation and has served in this position since July 2011. He has been a member of our Board since 2011 and has served as our Board's Chairman since March 2016. From November 2010 to July 2011, Mr. Collis served as President and Chief Operating Officer of AmerisourceBergen Corporation. He served as Executive Vice President and President of AmerisourceBergen Drug Corporation from September 2009 to November 2010, as Executive Vice President and President of AmerisourceBergen Specialty Group from September 2007 to September 2009 and as Senior Vice President of AmerisourceBergen Corporation and President of AmerisourceBergen Specialty Group from August 2001 to September 2007. Mr. Collis has held a variety of other positions with AmerisourceBergen Corporation and its predecessors since 1994. Mr. Collis is a member of the Board of CEOs Against Cancer (PA Chapter), and is a member of the American Red Cross Board of Governors. He previously served on the Board of International Federation of Pharmaceutical Wholesalers, Inc. until October 2018 and the board of Thoratec Corporation from 2008 to 2015.
As the Chairman of the Board、 President、 Chief Executive Officer of Amerisource Bergen, the total compensation of Steven Collis at Amerisource Bergen is 11,309,900$. There are no executives at Amerisource Bergen getting paid more.
Steven Collis is 58, he's been the Chairman of the Board、 President、 Chief Executive Officer of Amerisource Bergen since 2016. There are 13 older and 8 younger executives at Amerisource Bergen. The oldest executive at Amerisource Bergen Corp. is Jane Henney, 72, who is the Lead Independent Director.
Steven's mailing address filed with the SEC is 1 WEST FIRST AVENUE, , CONSHOHOCKEN, PA, 19428.
Over the last 21 years, insiders at Amerisource Bergen have traded over 4,389,593,610$ worth of Amerisource Bergen stock and bought 18,610 units worth 1,659,872$ . The most active insiders traders include Boots Alliance, Inc.Walgree...、Lon R Greenberg、Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of 13,111,903$. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth 813,987$.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: